Conversely, in prostate cancer, a carbon ion-treated patient experienced a decrease in tumor cells and rise in CD4+ cells and CD4+/CD8+ ratio during the RT and until 1 month after treatment. The gene discussed is CD4; the disease is prostate carcinoma.